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The quest for novel biological structures is a challenge in 
natural product-directed drug discovery. Marine environment has 
been offering a broad and valuable resource IRU KXPDQ¶V ORQJ
existence and development. Its biological richness and diversity 
attracted researchers to seek for unique and novel molecules from 
the previously underexplored sources, such as the deep sea 
sediments, marine algae, marine invertebrates, and their associated 
microbes. Marine sponge-associated microorganisms have 
exhibited a great potential in producing natural products with 
diverse medicinal and pharmaceutical properties [1-5]. In 
particular, sponge-associated actinomycetes made good records in 
providing a multitude of novel secondary metabolites [6, 7] with 
diverse biological activities, such as antimicrobial [8, 9], anti-
parasitic [10, 11], immunomodulatory [12], antichlamydial [13], 
anti-oxidant [7], and anticancer [14, 15] activities. Herein, we 
report on the structures and anti-cancer activities of one new 
phenoxazin analogue strepoxazine A (1), and two known 
phenazine analogues phencomycin (2) and tubermycin B (3) 
obtained from the solid extract of sponge-associated Streptomyces 
sp. SBT345.  
Streptomyces sp. SBT345, recovered from the Mediterranean 
sponge Agelas oroides, was plated out on ISP2 agar medium plate 
(120×120 mm, a total of 150 plates) and incubated at 30 °C for 5 
days. Colonies and agar were cut into small pieces and macerated 
with ethyl acetate. The ethyl acetate extract (630 mg) was 
fractionated on a Sephadex LH20 (32-64 µm, 100 x 10 mm, 
Merck) column eluting with H2O/MeOH (90:10%) to MeOH 
(100%), to yield 6 fractions. Fraction 5 was subjected to C18 
reversed-phase chromatography and led to the isolation of 
compounds 1-3. 
Figure 1. Structures of strepoxazine A (1), phencomycin (2), and 
tubermycin B (3) 
Compound 1 was obtained as a yellowish powder from fraction 
2 and the molecular formula was established as C17H14N2O6 by 
ESI-HR-MS (found at m/z 341.0766 [M - H]- , cald. 341.0774; and 
m/z 365.0757 [M + Na]+,  cald. 365.0750) requiring 11 degrees of 
unsaturation. The 1H NMR spectrum exhibited the resonances for 
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One new phenoxazin analogue, strepoxazine A (1), along with two known phenazine compounds 
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actinomycetes are rich sources for natural products with new pharmacological activities and 
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 six sp2 aromatic proton signals at įH 7.38 (1H, brs, H-1), 7.01 (1H, 
t, J = 7.9, 15.7 Hz, H-2), 7.93 (1H, d, J = 7.9 Hz, H-3), 7.19 (1H, 
d, J = 7.7  Hz, H-6), 7.24 (1H, t, J = 7.7, 15.4 Hz, H-7), 7.43 (1H, 
brs, H-8) ppm, of which two independent aromatic systems were 
observed based on the analysis of COSY spectrum. The HMBC 
cross-peaks from the aromatic protons of H-2 to įC 121.5 (1C, C-
10a) ppm, H-3 to įC 144.2 (1C, C-4a) ppm, H-7 to įC 142.5 (1C, 
C-5a) ppm, and H-6 to įC 125.0 (1C, C-9a) ppm led to the 
assignment of a phenoxazin nucleus [16], in which the carbon 
resonance of C-4a, C-5a, C-9a and C-10a were consistent with the 
other analogues in the literature exemplified by Venezueline C and 
Venezueline D [17]. Additional NMR data conducted to assign 
one carboxylic acid group to C-4 by correlation observed between 
H-3 and a carboxylic carbon at įC 173.3 (1C, C-11) ppm, and one 
methoxyl ester by correlation observed between the methoxyl 
protons at įH 3.88 (3H, s, H-15) ppm to the other carbonyl at įC 
168.5 (1C, C-14) ppm in the HMBC spectrum. The presence of the 
carboxylic acid group was further verified in ESI-HRMS/MS 
spectra (collision voltage of 10eV) by the loss mass of 43.9898 Da 
(cald. for COO) from the molecular ion mass m/z 341.0766 (cald. 
for C17H13N2O6
-) to fragment ion mass m/z 297.0867 (cald. for 
C16H13N2O4
-) (Figure 2). The presence of the methoxyl ester was 
also verified by the loss mass of 59. 0234 Da (cald. for C2H3O2) in 
both negative and positive ionisation modes from the molecular 
ion mass m/z 341.0766 (cald. for C17H13N2O6
-) to fragment ion 
mass m/z 282.0639 (cald. for C15H10N2O4
-) (Figure 2), as well as 
the molecular ion mass m/z 365.0757 (cald. for C17H14N2O6Na
+) to 
fragment ion mass m/z 306.0619 (cald. for C15H11N2O4Na
+) 
(Figure 3) respectively. The fragment ion mass m/z 265.0611 
(cald. for C15H9N2O3
-) in negative ionisation mode (Figure 2), and 
m/z 288.0515 (cald. for C15H9N2O3Na
+) in the positive ionisation 
mode (Figure 3) were deduced by losing the carboxylic acid and 
methoxyl groups from the molecular ion. Furthermore, m/z 
237.0662 (cald. for C14H9N2O2
-) and m/z 260.0564 (cald. for 
C14H9N2O2Na
+) were the products of losing both carboxylic acid 
group and methoxyl ester side chain (Figure 2 and 3). The high-
resolution fragment ion masses and the NMR data assigned the 
phenoxazine based structure, one carboxylic acid, and one 
methoxyl ester side chain which established a partial elementary 
composition as C15H11NO5. The remaining elements C2H3NO were 
deduced as an olefinic structure that substituted by a hydroxyl and 
an amine group, and connects between the methoxyl ester and the 
aromatic carbon C-9. The enol group was deduced to connect to 
C-13 due to the broad proton resonance at H-8 which could be 
affected by the intramolecular hydrogen bond with enol proton. 
The enamino proton was also speculated to form the other 
intramolecular hydrogen bond with the ketone oxygen at C-14 to 
form a keto-enamine structure, which makes the whole structure 
more stable than the presence of single enol or enamino group [18, 
19]. Additionally, the fragment ion mass m/z 209.0710 (cald. for 
C13H9N2O
-) presented in negative mass spectrum was interpreted  
with the structure shown in Figure 2 by the web server named as 
CFM-ID designed for annotation, spectrum prediction and 
metabolite identification from tandem mass spectra using the data 
from HMDB, MassBank, and Metlin databases [20]. The 
deprotonated imine at C-12 (Figure 2) further demonstrated the 
elucidation of enamino part.  
Compound 2 was isolated as yellow solid from fraction 3 and 
the molecular formula was established as C15H10N2O4 with 11 
degrees of unsaturation by ESI-HRMS (found at m/z 283.0710 [M 
+ H]+, cald. 283.0719 ). The 1H NMR and COSY spectra revealed 
six sp2 DURPDWLFSURWRQVDWįH 7.67 (1, d, J = 8.7 Hz, H-2), 7.88 
(1H, t, J = 8.7, 15.4 Hz, H-3), 8.02 (1H, d, J = 8.7 Hz, H-4), 8.19 
(1H, d, J = 8.7 Hz, H-7), 7.97 (1H, t, J = 8.7, 15.6 Hz, H-8), and 
8.38 (1H, d, J = 8.7 Hz, H-9) ppm in two different aromatic rings 
DQGPHWKR[\OSURWRQDWįH 4.01 (3H, s, H-13) ppm. The 1H-13C 
HMBC spectrum assigned the nine aromatic carbons įC 125.9 (1C, 
C-2), 127.3 (1C, C-4), 142.0 (1C, C-4a), 139.1 (1C, C-5a), 132.1 
(1C, C-6), 131.1 (1C, C-7), 132.0 (1C, C-9), 142.1 (1C, C-9a), 
140.4 (1C, C-10a) SSP DQG WZR FDUER[\OLF FDUERQ\OV įC 170.5 
(1C, C-11), and 167.8 (1C, C-12) ppm. The carbon resonances of 
C-4a, C-5a, C-9a, and C-10a indicated a phenazine based structure. 
An exact mass search in the Database of Natural Products and 
comparison of the spectral data with literature [21] determined 
compound 2 as a known phenazine compound phencomycin which 
was previously isolated from Streptomyces sp. derived from 
terrestrial [21, 22] and marine sources [23]. 
 
 
 
 
 
 
 
 
Figure 2. ESI-HRMS2 fragmentation of strepoxazine A in 
negative ionization mode 
 
 
 
 
 
 
 
Figure 3. ESI-HRMS2 fragmentation of strepoxazine A in positive 
ionization mode 
Compound 3 was isolated as yellow solid from fraction 3 and 
the molecular formula was established as C13H8N2O2 with 10 
degrees of unsaturation by ESI-HRMS (found at m/z 225.0655 [M 
+ H]+, cald. 225.0664). The 1H NMR revealed seven sp2 aromatic 
SURWRQVDWįH 8.72 (1H, d, J = 8.8 Hz, H-2), 8.12 (1H, m, H-3), 8.53 
(1H, d, J = 8.8 Hz, H-4), 8.37 (1H, d, J = 8.3 Hz, H-6), 8.08 (1H, 
m, H-7), 8.10 (1H, m, H-8), 8.34 (1H, d, J = 8.3 Hz, H-9) ppm in 
two different aromatic rings. The 1H-13C HMBC spectrum 
assigned eight aromatic carbons įC 133.3 (1C, C-2), 143.2 (1C, C-
5a), 129.7 (1C, C-6), 132.2 (1C, C-7), 131.6 (1C, C-8), 129.7 (1C, 
C-9), 143.2 (1C, C-9a), and 140.1 (1C, C-10a) ppm. A search in 
Database of Natural Products and comparison of spectral data with 
phencomycin and literatures [24, 25] resulted in a known 
phenazine compound tubermycin B which was previously isolated 
from Pseudomonas sp. [26] and Streptomyces sp. [25].  
Various phenoxazines and phenazines have been reported for 
their anticancer activities against a panel of tumor cell lines, 
including intestinal adenocarcinoma cell lines [17, 27], gastric 
 cancer cell lines [28-30], pancreatic cancer cell lines [31, 32], lung 
tumor cell lines [33-35], breast cancer cell lines [34-36], human 
hepatoma cell lines [17, 37, 38], multiple myeloma cell lines [39, 
40], and human promyelocytic leukemia cells [41-43], etc. The 
antiproliferative activity of compounds 1±3 were evaluated against 
human promyelocytic leukemia cells HL-60 and human breast 
adenocarcinoma cells MCF-7 using Vitality Test and MTT assay. 
The new phenoxazine strepoxazine A (1) exhibited significant 
cytotoxic properties against HL-60 with IC50 at 16 µg/ml. 
However, the other two phenazines 2 and 3 did not display any 
activity.  
In conclusion, strepoxazine 1 is a new phenoxazine analogue 
isolated from the solid culture of sponge-associated Streptomyces 
sp. SBT345. and exhibited potent apoptotic effect against human 
promyelocytic leukemia cells HL-60. The results presented in this 
paper highlight sponge-associated actinomycetes as a rich source 
for novel biologically active natural products.  
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